Feng Jialei, Wang Wei, Zhong Yuan, Xing Chonghui, Guo Taipin
Yunnan University of Chinese Medicine, Kunming, Yunnan.
Hospital of Traditional Chinese Medicine Affiliated to the Southwest Medical University, Luzhou, Sichuan.
Medicine (Baltimore). 2019 Feb;98(7):e14574. doi: 10.1097/MD.0000000000014574.
Perimenopausal depressive disorder (PDD) is a disease that plagues many perimenopausal women. There is an urgent need for a safe way to treat the disease. With few side effects, acupuncture treatment for PDD has been gradually accepted. However, at present, the evidence is insufficient and relevant studies are not in-depth enough. The purpose of this study is to explore the efficacy and safety of acupuncture for PDD.
All randomized controlled trials articles on acupuncture treatment of PDD will be searched in databases such as MEDLINE, EBASE, Cochrane Library, Springer, World Health Organization International Clinical Trials Registry Platform, China National Knowledge Infrastructure, Wan Fang, Chinese Biomedical Literature Database, Chinese Scientific Journal Database and so on. Non-RCT articles will be screened and key information will be extracted. The primary outcome is the Hamilton depression scale. Second outcomes are the Hamilton anxiety scale, Quality of life scale, changes of symptoms in traditional Chinese medicine and hormone levels.
This systematic review will provide the highest level of evidence and provide an evaluation of the efficacy and safety of acupuncture for PDD.
This study provides evidence for evaluating the efficacy and safety of acupuncture in the treatment of PDD.
CRD42018115811.
围绝经期抑郁症(PDD)是困扰众多围绝经期女性的一种疾病。迫切需要一种安全的治疗方法。针刺治疗PDD副作用少,已逐渐被接受。然而,目前证据不足,相关研究不够深入。本研究旨在探讨针刺治疗PDD的疗效和安全性。
检索MEDLINE、EBASE、Cochrane图书馆、Springer、世界卫生组织国际临床试验注册平台、中国知网、万方、中国生物医学文献数据库、中国科学期刊数据库等数据库中所有关于针刺治疗PDD的随机对照试验文章。筛选非随机对照试验文章并提取关键信息。主要结局指标为汉密尔顿抑郁量表。次要结局指标为汉密尔顿焦虑量表、生活质量量表、中医症状变化及激素水平。
本系统评价将提供最高级别的证据,并对针刺治疗PDD的疗效和安全性进行评价。
本研究为评价针刺治疗PDD的疗效和安全性提供了依据。
PROSPERO注册号:CRD42018115811。